Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan Gifford

Dentist, Periodontics Las Vegas, NV Doctor of Dentistry

NPI 1295996627 CMS profile 826621

3811 W Charleston Blvd, #201, Las Vegas, NV 89102

Open in the dashboard

General payments

$14,272

203 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ryan Gifford of Las Vegas, NV is reported in the CMS Open Payments database as having received $14,272 across 203 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $282 11
2024 General $575 9
2023 General $1,412 30
2022 General $839 38
2021 General $1,711 35
2020 General $680 30
2019 General $8,773 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Gifford
  • Dentist, Periodontics median
  • Middle half of Dentist, Periodontics
  • National median

In program year 2025, general payments to Ryan Gifford were reported at $282. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.

Show as a table
Year Ryan Gifford Dentist, Periodontics median Middle half National median
2019 $8,773 $129 $42–$367 $163
2020 $680 $90 $35–$265 $114
2021 $1,711 $125 $42–$411 $132
2022 $839 $123 $43–$364 $149
2023 $1,412 $125 $45–$358 $160
2024 $575 $119 $42–$350 $164
2025 $282 $112 $42–$307 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nobel Biocare USA $9,501 132 payments
  2. Straumann USA LLC $3,355 53 payments
  3. Keystone Dental Inc. $1,280 12 payments
  4. BioHorizons Implant Systems Inc. $90 4 payments
  5. Geistlich Pharma, North America, Inc. $31 1 payment
  6. OraPharma, a division of Bausch Health US, LLC $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $6,000 2 payments
  2. Food and Beverage $4,809 180 payments
  3. Gift $1,672 6 payments
  4. Entertainment $929 10 payments
  5. Education $457 3 payments
  6. Travel and Lodging $377 1 payment
  7. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27 1 payment
Products named General payments · program years 2019–2025
  1. NOBELPARALLEL $7,545 53 payments
  2. NOBELACTIVE Dental implant $7,545 53 payments
  3. NOBELACTIVE Dental implant $675 24 payments
  4. NOBELPROCERA $603 27 payments
  5. NOBELSPEEDY $603 27 payments
  6. NOBELREPLACE $594 26 payments
  7. BIOHORIZONS Implant Dentistry $90 4 payments
  8. BIOHORIZONS Implant Dentistry $90 4 payments
  9. BIOHORIZONS Implant Dentistry $90 4 payments
  10. BIOHORIZONS Implant Dentistry $90 4 payments
  11. Other $204 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

511

Median for Dentist: 47

Drug cost

$2,175

Median for Dentist: $159

Branded share of claims

3.5%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 247 $660
Dexamethasone Generic 14 $388
Chlorhexidine Gluconate Generic 83 $306
Cefdinir Generic 11 $300
Ibuprofen Generic 111 $245
Cephalexin Generic 27 $170
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $106

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

203 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Periodontics in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record